Legal updates and opinions
News / News
Compensation for employees who experience injuries, illness or death as a result of the Covid-19 vaccine
Compensation for Occupational Injuries and Diseases Act 130 of 1993
by Jacques van Wyk, Director and Andre van Heerden, Senior Associate
On 22 October 2021, a notice was published in the Government Gazette in terms of section 6A(b) of the Compensation for Occupational Injuries and Diseases Act 130 of 1993 (“COIDA“). The notice relates to the compensation for side effects to the Covid-19 vaccination (“Notice“) based on employees who experience injuries, illness or death as a result of the Covid-19 vaccine in the circumstances where the requirement to have the vaccine is an inherent requirement of the employee’s job or where the employee is required to do so in terms of his/her employer’s risk assessment.
Read our article discussing vaccination policies for the workplace for more on the implementation of a mandatory vaccination policy and the required risk assessment).
The Notice provides that if an employee is required to receive a Covid-19 vaccine, either as a result of an occupational health and safety risk assessment conducted by an employer or where the vaccine is an inherent requirement of employment, any injury, illness or death incurred as a result will be covered by the Compensation Fund.
However, in order for such cover to extend to an employee, there are 6 requirements that apply:
- The vaccine must be regarded as an inherent requirement of employment in terms of the employer’s risk assessment;
- The employee must have received a SAHPRA-approved Covid-19 vaccine;
- Evidence of the employer’s risk assessment and vaccination plan in terms of the Consolidated Directions on Occupational Health and Safety Measures in Certain Workplaces must be provided;
- The chronological sequence between the vaccine inoculation and the development of the employee’s symptoms and clinical signs must be provided;
- The employee must have presented with symptoms and clinical signs that are generally recognised as side effects of the Covid-19 vaccine; and
- Additional tests may be required to assess the presence of abnormalities of any organ affected.
A copy of the Notice can be accessed here.
Latest News
Funds in crisis – how do funds manage in times of crisis?
by Shayne Krige, Director and head of the Investment Funds & Private Equity practice It has been an interesting two [...]
Entities regulated by the FINANCIAL SECTOR CONDUCT AUTHORITY (“FSCA”)
by Hilah Laskov, Senior Associateand Chelsea Roux, Candidate AttorneyReviewed by Shayne Krige, Director and head of the Investment Funds & Private [...]
The right to privacy and the Amendments to the Disaster Management Regulations
by Jones Antunes, Director; Innocentia Moele; Senior Associate; and Danielle Hertz, Candidate Attorney On 1 April 2020 the Minister of [...]
Litigation during the lock-down
Pending litigation during lockdown On the evening of 30 March 2020, President Cyril Ramaphosa addressed the Nation, four days into the [...]
COVID-19 and funerals: What is the legal position?
by Naledi Motsiri, Director and Nelsie Siboza, Candidate Attorney Introduction The highly contagious and even deadly Coronavirus ("Covid‑19") has had [...]
COVID-19 tax relief measures
By Erich Bell, Director, Werksmans Tax Proprietary Limited The Draft Disaster Management Tax Relief Bill, 2020 and Disaster Management Tax [...]
